Signature Estate & Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,832
| Closed | -$214K | – | 580 |
|
|
2025
Q1 | $214K | Sell |
1,832
-800
| -30% | -$93.3K | 0.01% | 517 |
|
|
2024
Q4 | $223K | Hold |
2,632
| – | – | 0.01% | 485 |
|
|
2024
Q3 | $237K | Hold |
2,632
| – | – | 0.01% | 463 |
|
|
2024
Q2 | $212K | Hold |
2,632
| – | – | 0.01% | 478 |
|
|
2024
Q1 | $210K | Sell |
2,632
-405
| -13% | -$32.3K | 0.01% | 167 |
|
|
2023
Q4 | $242K | Hold |
3,037
| – | – | 0.01% | 166 |
|
|
2023
Q3 | $212K | Buy |
+3,037
| New | +$212K | 0.01% | 165 |
|
|
2023
Q1 | – | Sell |
-2,632
| Closed | -$203K | – | 176 |
|
|
2022
Q4 | $203K | Buy |
+2,632
| New | +$203K | 0.01% | 178 |
|
|
2021
Q1 | – | Sell |
-2,632
| Closed | -$214K | – | 165 |
|
|
2020
Q4 | $214K | Buy |
+2,632
| New | +$214K | 0.01% | 152 |
|
|
2020
Q3 | – | Sell |
-2,632
| Closed | -$217K | – | 151 |
|
|
2020
Q2 | $217K | Buy |
+2,632
| New | +$217K | 0.02% | 132 |
|
|
2020
Q1 | – | Sell |
-2,632
| Closed | -$272K | – | 133 |
|
|
2019
Q4 | $272K | Buy |
+2,632
| New | +$272K | 0.02% | 144 |
|